Interleukin and neurotrophin up-regulation correlates with severity of H1N1 infection in children: A case-control study

International Journal of Infectious Diseases

Volumn 17, Issue 12, 2013, Pages

  Chiaretti, Antonio ^a   Pulitanò, Silvia ^a   Conti, Giorgio ^a   Barone, Giovanni ^a   Buonsenso, Danilo ^a   Manni, Luigi ^b   Capozzi, Domenico ^a   Ria, Francesco ^a   Riccardi, Riccardo ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

Brain derived neurotrophic factor; Glial derived neurotrophic factor; H1N1 influenza; Interleukins; Nerve growth factor

Indexed keywords

AMOXICILLIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CEFTRIAXONE; CLARITHROMYCIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; NERVE GROWTH FACTOR; OSELTAMIVIR;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD LEVEL; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEVER; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; LOWER RESPIRATORY TRACT INFECTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PNEUMONIA; PNEUMOPERICARDIUM; PNEUMORACHIS; PNEUMOTHORAX; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RESPIRATORY CARE; SEIZURE; THORAX RADIOGRAPHY; TREATMENT DURATION; UPREGULATION; VIRAL BRONCHIOLITIS;

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL DERIVED NEUROTROPHIC FACTOR; H1N1 INFLUENZA; INTERLEUKINS; NERVE GROWTH FACTOR;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CYTOKINES; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERLEUKINS; PATIENT OUTCOME ASSESSMENT; POLYSACCHARIDES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84888437057     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.07.006     Document Type: Article

References (41)

1. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
2. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
3. Hasegawa M., Hashimoto K., Morozumi M., Ubukata K., Takahashi T., Inamo Y. Spontaneous pneumomediastinum complicating pneumonia in children infected with the 2009 pandemic influenza A (H1N1) virus. Clin Microbiol Infect 2010, 16:195-199.
4. Kamigaki T., Oshitani H. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr 2009, 1:RRN1139.
5. Epidemiological summary of pandemic influenza A (H1N1) 2009 virus Ontario, Canada, June 2009. Wkly Epidemiol Rec 2009, 84:485-492.
6. Yu X., Zhang X., Zhao B., Wang J., Zhu Z., Teng Z., et al. Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLoS One 2011, 6:e28680.
7. Estella A. Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 influenza A(H1N1)v severe pneumonia. J Infect Dev Ctries 2011, 5:540-543.
8. Maruo N., Morita I., Shirao M., Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology 1992, 131:710-714.
9. Julkunen I., Sareneva T., Pirhonen J., Ronni T., Melén K., Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001, 12:171-180.
10. Piedimonte G. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr Infect Dis J 2003, 22(2 Suppl):S66-S74. discussion:S74-5.
11. Hu C., Wedde-Beer K., Auais A., Rodriguez M.M., Piedimonte G. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol 2002, 283:494-502.
12. Jurgens H.A., Johnson R.W. Environmental enrichment attenuates hippocampal neuroinflammation and improves cognitive function during influenza infection. Brain Behav Immun 2012, 26:1006-1016.
13. Sheridan J.F., Stark J.L., Avitsur R., Padgett D.A. Social disruption, immunity, and susceptibility to viral infection. Role of glucocorticoid and NGF. Ann N Y Acad Sci 2000, 917:894-905.
14. Piedimonte G., Hegele R.G., Auais A. Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats. Pediatr Res 2004, 55:657-665.
15. Piedimonte G., Rodriguez M.M., King K.A., McLean S., Jiang X. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol 1999, 277:L831-L840.
16. King K.A., Hu C., Rodriguez M.M., Romaguera R., Jiang X., Piedimonte G. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol 2001, 24:101-107.
17. Freund-Michel V., Frossard N. The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol Ther 2008, 117:52-76.
18. El-Hashim A.Z., Jaffal S.M. Nerve growth factor enhances cough and airway obstruction via TrkA receptor- and TRPV1-dependent mechanisms. Thorax 2009, 64:791-797.
19. de Vries A., Dessing M.C., Engels F., Henricks P.A., Nijkamp F.P. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999, 159:1541-1544.
20. Braun A., Appel E., Baruch R., Herz U., Botchkarev V., Paus R., et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998, 28:3240-3251.
21. Jurgens H.A., Amancherla K., Johnson R.W. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci 2012, 32:3958-3968.
22. Urrego F., Scuri M., Auais A., Mohtasham L., Piedimonte G. Combined effects of chronic nicotine and acute virus exposure on neurotrophin expression in rat lung. Pediatr Pulmonol 2009, 44:1075-1084.
23. Tortorolo L., Langer A., Polidori G., Vento G., Stampachiacchere B., Aloe L., et al. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 2005, 172:233-237.
24. Othumpangat S., Gibson L.F., Samsell L., Piedimonte G. NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection. PLoS One 2009, 4:e6444.
25. Puneet P., Moochhala S., Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005, 288:L3-L15.
26. Meduri G.U., Kohler G., Headley S., Tolley E., Stentz F., Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995, 108:1303-1314.
27. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain Behav Immun 1995, 9:355-365.
28. Chang S.S., Vaz Fragoso C.A., Van Ness P.H., Fried L.P., Tinetti M.E. Association between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women's Health and Aging Studies I and II. J Am Geriatr Soc 2011, 59:113-119.
29. Sato M., Hosoya M., Wright P.F. Differences in serum cytokine levels between influenza virus A and B infection in children. Cytokine 2009, 47:65-68.
30. Wu C.L., Lee Y.L., Chang K.M., Chang G.C., King S.L., Chiang C.D., et al. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia. Crit Care Med 2003, 31:812-817.
31. Pires-Neto R.C., Morales M.M., Lancas T. Expression of acute-phase cytokines, surfactant proteins, and epithelial apoptosis in small airways of human acute respiratory distress syndrome. J Crit Care 2013, 28:111-115.
32. Patil G., Khan M.I., Patel D.K., Sultana S., Prasad R., Ahmad I. Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic responses of micro- and nano-particles of dolomite on human lung epithelial cells A(549). Environ Toxicol Pharmacol 2012, 34:436-445.
33. Chaudhuri R., McMahon A.D., McSharry C.P., Macleod K.J., Fraser I., Livingston E., et al. Serum and sputum neurotrophin levels in chronic persistent cough. Clin Exp Allergy 2005, 35:949-953.
34. Bonini S., Lambiase A., Bonini S., Angelucci F., Magrini L., Manni L., et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci U S A 1996, 93:10955-10960.
35. Nicol G.D., Vasko M.R. Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks. Mol Interv 2007, 7:26-41.
36. de Vries A., Engels F., Henricks P.A., Leusink-Muis T., McGregor G.P., Braun A., et al. Airway hyper-responsiveness in allergic asthma in guinea-pigs is mediated by nerve growth factor via the induction of substance P: a potential role for trkA. Clin Exp Allergy 2006, 36:1192-1200.
37. Olgart Höglund C., de Blay F., Oster J.P., Duvernelle C., Kassel O., Pauli G., et al. Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J 2002, 20:1110-1116.
38. Ehrhard P.B., Erb P., Graumann U., Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A 1993, 90:10984-10988.
39. Dagnell C., Grunewald J., Kramar M., Haugom-Olsen H., Elmberger G.P., Eklund A., et al. Neurotrophins and neurotrophin receptors in pulmonary sarcoidosis-granulomas as a source of expression. Respir Res 2010, 11:156.
40. Dagnell C., Grunewald J., Kramar M., Haugom-Olsen H., Elmberger G.P., Eklund A., et al. Role of CD4(+) T cells in the modulation of neurotrophin production in mice exposed to low-level toluene. Immunopharmacol Immunotoxicol 2009, 31:146-149.
41. Othumpangat S., Walton C., Piedimonte G. MicroRNA-221 modulates RSV replication in human bronchial epithelium by targeting NGF expression. PLoS One 2012, 7:e30030.